Ophelia amasses $50m Series B

Ophelia, a digital provider of medication-assisted treatment for opioid use disorder, has raised $50 million in Series B funding.

Ophelia, a digital provider of medication-assisted treatment for opioid use disorder, has raised $50 million in Series B funding. Tiger Global led the round with participation from other backers that included Menlo Ventures, General Catalyst, Refactor Capital, 640 Oxford Ventures and Interplay Ventures.

Source: Press Release